Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1072 | 1025 | 1114 | 1069 | 1237 | 1576 |
Fund Return | 7.23% | 2.47% | 11.38% | 2.25% | 4.34% | 4.65% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1993786604 | 1.38B | 11.14 | -12.62 | - | ||
LU1038903065 | 399.47M | 7.23 | 2.25 | 4.65 | ||
LU1046463953 | 399.47M | 7.22 | 2.25 | 4.66 | ||
UBSLuxEq GlblIncomeUSD SGD H Pmdist | 413.97M | 9.79 | 4.42 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Income Growth AM H2 | 51.41B | 6.35 | -0.39 | 5.89 | ||
LU0912757837 | 17.73B | 8.27 | 1.22 | 3.65 | ||
LU1391767313 | 350.64M | 0.08 | 4.37 | - | ||
FirstEagleAmundi IntlClassAHSC Shrs | 6.17B | 14.50 | 5.64 | 5.05 | ||
FirstEagleAmundi IntlClassAHSQDShrs | 6.17B | 14.47 | 5.66 | 5.03 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UBS (Lux) BFConvert Eurp EUR U-X EUR Inc | LU0415180149 | 18.75 | - | - | |
UBS Lux Equity SICAV - European Opportunity Uncons | LU0549584711 | 18.34 | 41,700.150 | -0.24% | |
UBS(LUX) ES Eurp Hi DivSsEUR U-X-acc | LU0566497789 | 14.58 | - | - | |
UBS Lux Bond SICAV - Convert Global EUR I-X-dist | LU0396332644 | 14.46 | 186.570 | -0.18% | |
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 0.63 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Strong Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review